| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-11 17:33:07 UTC |
|---|
| Update Date | 2022-03-07 02:52:19 UTC |
|---|
| HMDB ID | HMDB0029864 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline |
|---|
| Description | 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline, also known as 8-methyl-iqx or 8-meiqx, belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline. |
|---|
| Structure | CN1C(N)=NC2=C1C=CC1=C2N=C(C)C=N1 InChI=1S/C11H11N5/c1-6-5-13-7-3-4-8-10(9(7)14-6)15-11(12)16(8)2/h3-5H,1-2H3,(H2,12,15) |
|---|
| Synonyms | | Value | Source |
|---|
| 2-Amino-3,8-dimethyl-3H-imidazo(4,5-F)quinoxaline | ChEBI | | 2-Amino-3,8-dimethylimidazo[4,5-F]quinoxaline | ChEBI | | 8-MeIQX | ChEBI | | 8-Methyl-iqx | ChEBI | | 2-amino-3,8-dimethylimidazo(4,5-F)Quinoxaline | HMDB, MeSH | | 2-amino-3,8-dimethylimidazo[4,5-F ]Quinoxaline | HMDB | | 3,8-DiMeIQX | HMDB, MeSH | | 3,8-Dimethyl-3H-imidazo(4,5-F)quinoxalin-2-amine | HMDB | | 3,8-Dimethyl-3H-imidazo[4,5-F]quinoxalin-2-amine | HMDB | | 3,8-Dimethyl-3H-imidazo[4,5-F]quinoxalin-2-amine, 9ci | HMDB | | 3,8-dimethylimidazo(4,5-F)Quinoxaline-2-amine | HMDB, MeSH | | Me-iqx | HMDB, MeSH | | MeIQx | HMDB | | Meiqx CPD | HMDB, MeSH |
|
|---|
| Chemical Formula | C11H11N5 |
|---|
| Average Molecular Weight | 213.2385 |
|---|
| Monoisotopic Molecular Weight | 213.101445377 |
|---|
| IUPAC Name | 3,8-dimethyl-3H-imidazo[4,5-f]quinoxalin-2-amine |
|---|
| Traditional Name | 3,8-dimethylimidazo[4,5-f]quinoxalin-2-amine |
|---|
| CAS Registry Number | 77500-04-0 |
|---|
| SMILES | CN1C(N)=NC2=C1C=CC1=C2N=C(C)C=N1 |
|---|
| InChI Identifier | InChI=1S/C11H11N5/c1-6-5-13-7-3-4-8-10(9(7)14-6)15-11(12)16(8)2/h3-5H,1-2H3,(H2,12,15) |
|---|
| InChI Key | DVCCCQNKIYNAKB-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazanaphthalenes |
|---|
| Sub Class | Benzodiazines |
|---|
| Direct Parent | Quinoxalines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Quinoxaline
- Benzimidazole
- Aminoimidazole
- Benzenoid
- Pyrazine
- N-substituted imidazole
- Azole
- Heteroaromatic compound
- Imidazole
- Azacycle
- Primary amine
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Organic nitrogen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 295 - 300 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | 1.01 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 2.24 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.3624 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.3 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 135.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 729.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 263.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 74.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 160.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 70.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 307.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 268.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 720.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 602.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 38.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 693.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 158.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 179.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 674.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 550.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 293.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline,1TMS,isomer #1 | CC1=CN=C2C=CC3=C(N=C(N[Si](C)(C)C)N3C)C2=N1 | 2531.8 | Semi standard non polar | 33892256 | | 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline,1TMS,isomer #1 | CC1=CN=C2C=CC3=C(N=C(N[Si](C)(C)C)N3C)C2=N1 | 2245.7 | Standard non polar | 33892256 | | 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline,2TMS,isomer #1 | CC1=CN=C2C=CC3=C(N=C(N([Si](C)(C)C)[Si](C)(C)C)N3C)C2=N1 | 2445.6 | Semi standard non polar | 33892256 | | 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline,2TMS,isomer #1 | CC1=CN=C2C=CC3=C(N=C(N([Si](C)(C)C)[Si](C)(C)C)N3C)C2=N1 | 2386.4 | Standard non polar | 33892256 | | 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline,1TBDMS,isomer #1 | CC1=CN=C2C=CC3=C(N=C(N[Si](C)(C)C(C)(C)C)N3C)C2=N1 | 2718.2 | Semi standard non polar | 33892256 | | 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline,1TBDMS,isomer #1 | CC1=CN=C2C=CC3=C(N=C(N[Si](C)(C)C(C)(C)C)N3C)C2=N1 | 2424.0 | Standard non polar | 33892256 | | 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline,2TBDMS,isomer #1 | CC1=CN=C2C=CC3=C(N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N3C)C2=N1 | 2777.6 | Semi standard non polar | 33892256 | | 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline,2TBDMS,isomer #1 | CC1=CN=C2C=CC3=C(N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N3C)C2=N1 | 2807.1 | Standard non polar | 33892256 |
|
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline EI-B (Non-derivatized) | splash10-03di-9630000000-e8a4917bbc669d325e41 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline EI-B (Non-derivatized) | splash10-03di-9630000000-e8a4917bbc669d325e41 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline GC-MS (Non-derivatized) - 70eV, Positive | splash10-053i-0900000000-0d6af152818e5f530c3d | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline APCI-ITFT , negative-QTOF | splash10-0002-0900000000-03d709fe2574ca7fec31 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline ESI-ITFT , positive-QTOF | splash10-03di-0390000000-8ed87f2afa42aabd3d50 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline APCI-ITFT , positive-QTOF | splash10-006t-0910000000-90504cc9714205cd22e3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 30V, Positive-QTOF | splash10-03dj-0980000000-50411c62b97c8360d105 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 40V, Positive-QTOF | splash10-0002-0900000000-11e6669d06720d9153bd | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 20V, Positive-QTOF | splash10-03di-0090000000-f43e697cafe001331dbe | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 10V, Positive-QTOF | splash10-03di-0090000000-159c1d3a85e946b03eca | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 50V, Positive-QTOF | splash10-008a-0900000000-36b0714ea24bc0b0f53c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 30V, Positive-QTOF | splash10-03dj-0980000000-52e3471483370bb41dd4 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 35V, Positive-QTOF | splash10-03di-0390000000-07cadffeea6f6a02ab84 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 10V, Positive-QTOF | splash10-03di-0090000000-3d4e5561b68230947db9 | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 20V, Positive-QTOF | splash10-03di-0590000000-9909fec9d9bf2ce2c608 | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 40V, Positive-QTOF | splash10-053r-1900000000-fa1c95b62ff0a0d20450 | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 10V, Negative-QTOF | splash10-03di-0090000000-75942ba4bbc76a904bf8 | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 20V, Negative-QTOF | splash10-03di-0390000000-123f616c3a9c164347fc | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 40V, Negative-QTOF | splash10-002b-3900000000-2678374bc011990ab3ac | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 10V, Negative-QTOF | splash10-03di-0090000000-30d0b34fa4acc6bca290 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 20V, Negative-QTOF | splash10-03di-0390000000-4fe19f6505755b2da029 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 40V, Negative-QTOF | splash10-001i-0920000000-a36acb9976b8ad2b2f1a | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 10V, Positive-QTOF | splash10-03di-0090000000-36fa26cf92b7f44a3ce6 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 20V, Positive-QTOF | splash10-03di-0090000000-e822b8dab153205d5822 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Amino-3,8-dimethyl-3H-imidazo[4,5-f]quinoxaline 40V, Positive-QTOF | splash10-052f-0900000000-86a61ce4e597d5f3de49 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | |
|---|
| Biospecimen Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| Not Available |
|---|
| Abnormal Concentrations |
|---|
| Not Available |
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | None |
|---|
| Associated OMIM IDs | None |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB001093 |
|---|
| KNApSAcK ID | Not Available |
|---|
| Chemspider ID | 56076 |
|---|
| KEGG Compound ID | C19255 |
|---|
| BioCyc ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PubChem Compound | 62275 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 76604 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| MarkerDB ID | Not Available |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| Material Safety Data Sheet (MSDS) | Not Available |
|---|
| General References | - Zaidi R, Kumar S, Rawat PR: Rapid detection and quantification of dietary mutagens in food using mass spectrometry and ultra performance liquid chromatography. Food Chem. 2012 Dec 15;135(4):2897-903. doi: 10.1016/j.foodchem.2012.07.065. Epub 2012 Jul 20. [PubMed:22980887 ]
- Aschebrook-Kilfoy B, Ollberding NJ, Kolar C, Lawson TA, Smith SM, Weisenburger DD, Chiu BC: Meat intake and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2012 Oct;23(10):1681-92. doi: 10.1007/s10552-012-0047-2. Epub 2012 Aug 14. [PubMed:22890783 ]
- Gibis M, Weiss J: Antioxidant capacity and inhibitory effect of grape seed and rosemary extract in marinades on the formation of heterocyclic amines in fried beef patties. Food Chem. 2012 Sep 15;134(2):766-74. doi: 10.1016/j.foodchem.2012.02.179. Epub 2012 Mar 10. [PubMed:23107689 ]
- Guo H, Pan H, Wang Z, Chen L, Zhang D: [Simultaneous determination of nine heterocyclic aromatic amines in mutton products by solid phase extraction-high performance liquid chromatography]. Se Pu. 2012 Oct;30(10):1074-80. [PubMed:23383498 ]
- Liao GZ, Wang GY, Zhang YJ, Xu XL, Zhou GH: Formation of heterocyclic amines during cooking of duck meat. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(11):1668-78. doi: 10.1080/19440049.2012.702928. Epub 2012 Jul 30. [PubMed:22838849 ]
- Hayashi H, Taniai E, Morita R, Hayashi M, Nakamura D, Wakita A, Suzuki K, Shibutani M, Mitsumori K: Enhanced liver tumor promotion but not liver initiation activity in rats subjected to combined administration of omeprazole and beta-naphthoflavone. J Toxicol Sci. 2012;37(5):969-85. [PubMed:23038005 ]
- Wei M, Kakehashi A, Yamano S, Tamano S, Shirai T, Wanibuchi H, Fukushima S: Lack of Hepatocarcinogenicity of Combinations of Low Doses of 2-amino-3, 8-dimethylimidazo[4,5- f ]quinoxaline and Diethylnitrosamine in Rats: Indication for the Existence of a Threshold for Genotoxic Carcinogens. J Toxicol Pathol. 2012 Sep;25(3):209-14. doi: 10.1293/tox.25.209. Epub 2012 Oct 1. [PubMed:22988339 ]
- Miller PE, Lazarus P, Lesko SM, Cross AJ, Sinha R, Laio J, Zhu J, Harper G, Muscat JE, Hartman TJ: Meat-related compounds and colorectal cancer risk by anatomical subsite. Nutr Cancer. 2013;65(2):202-26. doi: 10.1080/01635581.2013.756534. [PubMed:23441608 ]
- (). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .
|
|---|